Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

ities and Exchange Commission on March 12, 2013. In addition, any forward-looking statements represent BioLineRx's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. BioLineRx does not assume any obligation to update any forward-looking statements unless required by law.

Contact:Garth Russell / Todd Fromer
KCSA Strategic Communications
1 212-896-1250 / 1 212-896-1215
grussell@kcsa.com / tfromer@kcsa.com

Tsipi Haitovsky
Public Relations
+972-3-6240871
tsipih@netvision.net.il

 BioLineRx Ltd.CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION(UNAUDITED)Convenience
translation into
USDDecember 31,September 30,September 30,201220132013NIS in thousandsIn thousandsAssetsCURRENT ASSETSCash and cash equivalents

68,339

42,961

12,146Short-term bank deposits

11,459

28,688

8,111Prepaid expenses

804

809

229Other receivables

2,254

875

247Total current assets

82,856

73,333

20,733,NON-CURRENT ASSETSRestricted deposits

3,513

1,933

547Long-term prepaid expenses

204

144

41Property and equipment, net

3,172

2,681

758Intangible assets, net

1,063

911

257Total non-current assets

7,952

5,669

1,603Total assets90,808

79,002

22,336Liabilities and equityCURRENT LIABILITIESCurrent maturities of long-term bank loan

137

-

-Accounts payable and accruals:Trade

12,283

12,564

3,552OCS

6,148

-

-Other

5,443

2,896

819Total current
'/>"/>

SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Middle Eastern MRI systems market is fast growing. MRI being ... of medicine like cardiology, neurology and orthopedics. It is replacing ... is as safer tool as it does not use ionizing ... into Open system, closed system and straight or upright system. ... it is preferred over that currently common closed type as ...
(Date:6/1/2015)... June 1, 2015  Diomics, an innovator in DNA ... , global financial executive, has joined Diomics, board of ... than 25 years of industry experience in broad global ... a managing director at Credit Suisse and JP Morgan, ... Witter. "Diomics is on the forefront of ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global Power Wheelchair Industry Report 2014" ... Global Power Wheelchair Industry Report 2014 is a ... of the power wheelchair industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3Richard M. Weissman joins Diomics Board of Directors 2Global Power Wheelchair Industry Trends 2015-2020 2
... The Leukemia & Lymphoma,Society has awarded a $550,000 ... Wilmot Cancer Center at the University of Rochester Medical,Center. ... funding the first two years of the five-year program., ... will support,Dr. Friedberg,s work on a new targeted treatment ...
... Assay Submitted for FDA Clearance, SAN DIEGO, July ... and Company) (NYSE: BDX ), announced today the ... the rapid diagnosis,of patients with Clostridium difficile infection (CDI). ... simplicity and speed in one test,procedure. BD has also ...
Cached Medicine Technology:University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3
(Date:6/1/2015)... 01, 2015 There’s never a good time ... comes to non-emergency, minor illnesses. , As of June 1, ... access to medical care via the Internet. Patients throughout Illinois ... or computer. , “Everyone is busy. We know that getting ... so we want to make it easier,” said Jeffry Tillery, ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Listen to ... established automotive companies are using more granular data to ... two comparatively new industry voices in Josep Celaya Gonzalez, ... winning start-up ParkTAG. As an automotive insurer, MAPFRE are ... as an easy-to-use solution to the driver. Award winning ...
(Date:6/1/2015)... InstantLabs will co-develop and commercialize a ... a Cooperative Research and Development Agreement (CRADA) with the ... with U.S. Farm Bill legislation, only members of the ... the United States. , InstantLabs’ DNA-based technology will ... need rather than requiring samples be sent to centralized ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 This is ... Annual GrowRIVERSIDE Conference: The Future of Local Food, June ... conference will assist cities in examining and ... urban agriculture infrastructure. , Organized for the city of ... feature a broad lineup of speakers ranging from urban ...
(Date:6/1/2015)... Strategic Radiology (SR) announced today that Rome Radiology ... the SR coalition of progressive, independent radiology groups geographically ... now have access to collective resources in all aspects ... deployment of subspecialized radiology services. With the addition of ... US based radiology group practices. , “We are ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... 4th Leading Cause of Death in U.S., SWANTON, ... Awareness Month, to help raise awareness about Chronic,Obstructive Pulmonary ... AllerAir will be making downloadable,tips available to COPD patients ... their November newsletter and blogs to raising awareness,about this ...
... TORONTO, Nov. 3 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,a ... cancer therapies, announced today that Dr. Alan M.,Ezrin, ... will present a,corporate update at Rodman & Renshaw ... New York City from November 10th - 12th ...
... /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) ... Exchange ("TSX") that it is reviewing the eligibility of ... The Company is being reviewed under the TSX,s ... comply with all requirements for continued,listing. If the Company ...
... cash flow from operations, updated guidance, and new stock ... ... (Nasdaq: AMCS ), a,leader in radiology and medical image and ... ended,September 30, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ...
... out than those without deployed kin , , MONDAY, Nov. 3 ... Iraq and Afghanistan are more likely to have behavioral problems ... , Researchers studied 169 families with children aged 18 months ... at a Marine base. , Of those families, 55 (33 ...
... Cox-1 drugs, like naproxen, study says , , MONDAY, Nov. ... attack that comes with the use of nonsteroidal anti-inflammatory ... to the specific pain-causing molecule they act against, a ... between the degree of inhibition in vitro [in the ...
Cached Medicine News:Health News:AllerAir Dedicates November to COPD Awareness Month 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 2Health News:Bradmer to present at Rodman & Renshaw Healthcare Conference 3Health News:Listing Review initiated by the Toronto Stock Exchange 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 2Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 3Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 4Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 5Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 6Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 7Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 8Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 9Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 10Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 11Health News:AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008 12Health News:Kids With Parent in War Zone Face Behavior Risks 2Health News:Study Sheds Light on Painkillers' Heart Risk 2Health News:Study Sheds Light on Painkillers' Heart Risk 3